ArticlePediatric research2026
Impact of being small for gestational age in neonates born below 600 g birth weight.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere are controversial data regarding the impact of being small for gestational age (SGA) on outcome of infants born below 600 g. Comparing mortality, morbidities and neurodevelopmental outcome at 2-3 years in GA-matched very low birth weight neonates born SGA vs. appropriate for gestational age (AGA).
methodsRetrospective single centre matched cohort study including infants born ≥22 weeks GA 2012-2022. Study group was defined as ≤600 g birthweight and SGA and matched with AGA controls for GA, sex, and year of birth.
resultsA total of 103 SGA and 103 AGA infants were matched. SGA neonates had higher rates of surfactant administration, surgically treated persistent ductus arteriosus, bronchopulmonary dysplasia, and retinopathy of prematurity intervention. Survival until discharge was 56% in SGA and 85% in AGA neonates. Using Bayley Scales of Infant Development at 2-3 years 42% of SGA and 66% of AGA infants showed normal cognitive outcome, 45% SGA and 60% AGA infants had normal motor development. Severe neurodevelopmental impairment was present in 10 SGA (26%) and 12 AGA survivors (18%, p = 0.102).
conclusionSGA patients exhibited significantly higher mortality rates and increased incidences of short-term morbidities compared to AGA neonates. Significant difference regarding cognitive and motor development was observed. IMPACT: There is a lack of studies examining the differences between SGA and AGA infants, particularly within the very low birth weight (VLBW) category. Despite this gap, SGA infants continue to face notable disadvantages. This paper contributes novel insights into the outcomes of VLBW SGA patients. Survival rate was 56% in SGA compared to 85% in AGA neonates. A total of 26% of SGA and 18% of AGA infants experienced severe neurodevelopmental impairment. The study's findings may pave the way for improved parental counselling, by providing valuable centre-based data to ensure informed decision-making and support families more effectively in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.